Latest Sirtex Medical Limited Stories
SYDNEY, March 17, 2015 /PRNewswire/ -- - In the first-line treatment of non-resectable metastatic colorectal cancer: - SIRFLOX study
SYDNEY, January 29, 2015 /PRNewswire/ -- Combined data from more than 1,000 patients being collected to assess overall survival (OS) benefit of adding first-line
BONN, Germany, September 29, 2014 /PRNewswire/ -- Newly published European Society for Medical Oncology (ESMO) clinical guidelines for the treatment of metastatic colorectal
PRINCETON, N.J., March 24, 2014 /PRNewswire/ -- Sirtex Medical Limited (ASX: SRX) and Guerbet S.A.
- The parings of haberdine; also, any kind of fragments.